Inhibiteurs d'angiotensine i-chymase(s), comprenant la chymase cardiaque humaine
作者： Dennis J. Hoover
DOI:
关键词:
摘要: Compose de la formule (I) permettant prevenir ou traiter efficacement l'hypertension, l'insuffisance cardiaque, l'infarctus du myocarde, l'hypertrophie cardiaque et ventricule gauche, les affections des arteres coronaires comprenant vasculaire, ainsi que lesions vasculaires resultant d'affections renales diabetiques non diabetiques, associees a l'angioplastie l'aetheroma.
参考文章(4)
H Urata, A Kinoshita, K S Misono, F M Bumpus, A Husain, Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. Journal of Biological Chemistry. ,vol. 265, pp. 22348- 22357 ,(1990) , 10.1016/S0021-9258(18)45712-2
A. Kinoshita, H. Urata, F.M. Bumpus, A. Husain, Multiple determinants for the high substrate specificity of an angiotensin II-forming chymase from the human heart. Journal of Biological Chemistry. ,vol. 266, pp. 19192- 19197 ,(1991) , 10.1016/S0021-9258(18)54981-4
Norton P. Peet, Joseph P. Burkhart, Michael R. Angelastro, Eugene L. Giroux, Shujaath Mehdi, Philippe Bey, Michael Kolb, Bernhard Neises, Daniel Schirlin, Synthesis of peptidyl fluoromethyl ketones and peptidyl alpha-keto esters as inhibitors of porcine pancreatic elastase, human neutrophil elastase, and rat and human neutrophil cathepsin G. Journal of Medicinal Chemistry. ,vol. 33, pp. 394- 407 ,(1990) , 10.1021/JM00163A063
Charles A. Kettner, Roger Bone, David A. Agard, William W. Bachovchin, Kinetic properties of the binding of alpha-lytic protease to peptide boronic acids. Biochemistry. ,vol. 27, pp. 7682- 7688 ,(1988) , 10.1021/BI00420A017